Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Augmedix, Inc. (AUGX : NSDQ)
 
 • Company Description   
Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in SAN FRANCISCO, Calif.

Number of Employees: 97

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.46 Daily Weekly Monthly
20 Day Moving Average: 143,075 shares
Shares Outstanding: 37.16 (millions)
Market Capitalization: $128.57 (millions)
Beta:
52 Week High: $10.00
52 Week Low: $2.84
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -6.74% -3.83%
12 Week -30.66% -31.35%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
111 SUTTER STREET SUITE 1300
-
SAN FRANCISCO,CA 94104
USA
ph: 888-669-4885
fax: -
investors@augmedix.com http://www.augmedix.com
 
 • General Corporate Information   
Officers
Emmanuel Krakaris - Chief Executive Officer; President; Secretary and
Gerard van Hamel Platerink - Chairman of the Board of Directors
Paul Ginocchio - Chief Financial Officer
Jennifer Carter - Director
Jason Krikorian - Director

Peer Information
Augmedix, Inc. (HLIS)
Augmedix, Inc. (APYI)
Augmedix, Inc. (RNVA)
Augmedix, Inc. (HMSY)
Augmedix, Inc. (LRSI)
Augmedix, Inc. (HAXS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 05105P107
SIC: 7389
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/08/22
Share - Related Items
Shares Outstanding: 37.16
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $128.57 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.69 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 6.39
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 35.29%
Sales Growth
vs. Year Ago Period: 32.51%
vs. Previous Quarter: 8.74%
ROE
09/30/21 - -
06/30/21 - -
03/31/21 - -3,261.14
ROA
09/30/21 - -67.87
06/30/21 - -91.46
03/31/21 - -118.21
Current Ratio
09/30/21 - 1.56
06/30/21 - 2.03
03/31/21 - 2.46
Quick Ratio
09/30/21 - 1.56
06/30/21 - 2.03
03/31/21 - 2.46
Operating Margin
09/30/21 - -80.43
06/30/21 - -93.05
03/31/21 - -91.14
Net Margin
09/30/21 - -80.43
06/30/21 - -93.05
03/31/21 - -91.14
Pre-Tax Margin
09/30/21 - -80.43
06/30/21 - -93.05
03/31/21 - -91.14
Book Value
09/30/21 - -0.19
06/30/21 - -0.17
03/31/21 - -0.04
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Capital
09/30/21 - -
06/30/21 - -
03/31/21 - -
 

Powered by Zacks Investment Research ©